Figure 4
PFS in patients with multiple myeloma with the del(13) abnormality. PFS was better with auto/RICallo: 31% vs 10% (P = .016) at 60 months and 21% vs 5% at 96 months (P = .026). All patients with del(13) included—ITT. Gray = auto/RICallo; black = auto.

PFS in patients with multiple myeloma with the del(13) abnormality. PFS was better with auto/RICallo: 31% vs 10% (P = .016) at 60 months and 21% vs 5% at 96 months (P = .026). All patients with del(13) included—ITT. Gray = auto/RICallo; black = auto.

Close Modal

or Create an Account

Close Modal
Close Modal